Qelbree is a medication that is primarily prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) in pediatric patients aged 6 to 17 years. It is a brand-name drug containing the active ingredient viloxazine hydrochloride, which belongs to a class of drugs known as selective norepinephrine reuptake inhibitors (NRI). Qelbree is designed to help manage symptoms associated with ADHD, such as inattention, hyperactivity, and impulsivity.
Uses
Qelbree is prescribed to individuals diagnosed with ADHD in order to aid in the management of symptoms. It works by increasing the amount of norepinephrine, a chemical messenger in the brain that plays a role in regulating attention and behavior. Qelbree may help improve a person’s ability to concentrate, control impulsive behavior, and manage hyperactivity.
Benefits
The benefits of Qelbree are often seen in individuals with ADHD who struggle with attention, impulsivity, and hyperactivity. By targeting norepinephrine reuptake, Qelbree may enhance cognitive abilities, increase attention span, and reduce hyperactive and impulsive behaviors. It can contribute to an improved quality of life for patients with ADHD and help them better function in academic, work, and social settings.
Side Effects
As with any medication, Qelbree can potentially cause side effects, although not everyone will experience them. The most common side effects associated with Qelbree include sleep-related problems, such as insomnia or hypersomnia (excessive sleepiness), decreased appetite, and nausea. Other possible side effects may include vomiting, abdominal pain, increased heart rate, irritability, fatigue, and mood swings. It is important to consult with a healthcare professional if any side effects persist or worsen.
Warnings
Before starting Qelbree, it is crucial to inform your healthcare provider about your medical history, especially if you have a history of heart problems, uncontrolled high blood pressure, liver disease, or seizures. Qelbree can potentially interact with other medications, so it is essential to disclose all current medications, including prescription drugs, over-the-counter medications, and herbal supplements. Qelbree may enhance the effects of alcohol, so alcohol consumption should be avoided while taking this medication. Additionally, it is important to follow proper dosage instructions and not abruptly discontinue the drug without consulting a healthcare professional.
FAQs
The effectiveness of Qelbree varies from individual to individual. In clinical studies, positive effects were observed within a few weeks of initiating treatment, while for some individuals, it may take longer. It is essential to discuss your progress with your healthcare provider to determine the optimal treatment duration for you.
The concurrent use of Qelbree with other ADHD medications is not recommended. It is crucial to inform your healthcare provider about all medications you are currently taking so that they can assess potential drug interactions and determine the most suitable treatment plan for you.
No, Qelbree is not considered addictive. It does not belong to the stimulant class of ADHD medications, reducing the risk of abuse or addiction commonly associated with other ADHD drugs.
Qelbree is only approved for use in pediatric patients aged 6 to 17 years by the Food and Drug Administration (FDA). It has not been studied or approved for use in children under the age of 6.
The safety of Qelbree during pregnancy or breastfeeding has not been established. It is important to consult with a healthcare professional if you are pregnant, planning to become pregnant, or breastfeeding to assess the potential risks and benefits of using Qelbree.
 in pediatric patients aged 6 to 17 years.){kind=link}